Related Experiment Video
Updated: Aug 12, 2026
Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
[Tissue plasminogen activator as a prognostic factor in myocardial infarct patients]
P Fernández Abellán1, F Marín Ortuño, P Marco Vera
1Servicio de Hematología, Hospital General Universitario de Alicante.
Insights
Changes in blood clotting (hemostasis) can lead to heart attacks. In heart attack survivors, elevated tissue plasminogen activator (t-PA) levels predict future coronary events.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Thrombosis Research
Context:
- Hypercoagulability is a known risk factor for initial ischemic heart disease and myocardial infarction.
- The role of hemostatic changes in recurrent coronary events post-infarction remains unclear.
- Understanding these factors is crucial for managing patients after a first heart attack.
Purpose:
- To investigate the prognostic value of hemostatic markers in patients who have survived a first myocardial infarction.
- To determine if specific blood concentrations of fibrinogen, t-PA, PAI, and FRW predict new ischemic events.
- To identify key indicators for poor prognosis in post-infarction patients.
Summary:
- A cohort of 58 myocardial infarction survivors was assessed for cardiovascular risk factors and blood levels of fibrinogen, t-PA, PAI, and FRW.
- Patients were followed for two years to monitor the occurrence of new ischemic problems.
- Only tissue plasminogen activator (t-PA) concentration emerged as a significant predictor of adverse outcomes.
Impact:
- Identifies tissue plasminogen activator (t-PA) as a critical biomarker for predicting recurrent ischemic events in myocardial infarction survivors.
- Provides valuable insights for risk stratification and personalized treatment strategies in cardiology.
- Highlights the importance of monitoring hemostatic parameters in cardiac patient management.
Abstract:
Changes in hemostasis inducing hypercoagulability are pathogenic factors for the development of ischemic heart disease and myocardial infarction. Nevertheless, their role is unknown in the emergence of new coronary events in patients with infarction. A group of 58 patients who had survived to a first infarction episode were studied; the cardiovascular risk factors were determined and blood concentrations of fibrinogen, t-PA, PAI and FRW measured. These patients were followed for two years to observe the development of new ischemic problems. In the study only the t-PA concentration was found to be a factor for poor prognosis.
